Effect of Alzheimer's disease risk factors on P300 evoked potential

Authors

Keywords:

cognitive dysfunction, Alzheimer's disease, risk factors, P300 evoked potential.

Abstract

Introduction: Evoked potentials have proven their sensitivity to early effects of Alzheimer's disease on cognitive functions.

Aim: To evaluate the effect of Alzheimer's disease risk factors on the P300 potential related to cognitive events.

Methods: An experimental case-control study was performed. The sample was non-probabilistic and consisted of 58 subjects at the authors' discretion. It was evaluated through the Minimental Test, and the P300 potential, related to cognitive events, was recorded in auditory modality. A multivariate analysis (Manova) was performed to determine the impact of risk factors on latency and amplitude.

Results: The level of cognitive functioning (p = 0.045), arterial hypertension (p = 0.003) and its association with hyperlipidemia (p = 0.023), schooling level (p = 0.04), overweight and obesity (p = 0.044) had an impact on P300 latency. Type 2 diabetes mellitus, although it had a significant effect on latency (p = 0.025), was not associated with its prolongation. Arterial hypertension plus hyperlipidemia (p = 0.011) and premenopausal oophorectomy (p = 0.044) significantly impacted amplitude.

Conclusions: The effect on cognitive impairment of arterial hypertension, arterial hypertension plus hyperlipidemia, overweight and obesity, premenopausal oophorectomy and low level of schooling can be demonstrated in the preclinical stage of Alzheimer's disease by P300 evoked potential. This confirms its advantages as an electrophysiological biomarker.

Downloads

Download data is not yet available.

Author Biographies

Arquímedes Montoya Pedrón, Hospital General Dr. Juan Bruno Zayas Alfonso. Universidad de Ciencias Médicas de Santiago de Cuba.

Doctor en Ciencias Médicas. Especialista de Primer y Segundo Grado en Neurofisiología Clínica. Profesor Titular e Investigador Titular. Jefe del servicio de Neurofisiología del Hospital General Docente Dr. Juan Bruno Zayas Alfonso.

Manuel Felipe Moreno Soto, Hospital Universitario Clínico Quirúrgico Dr. Ambrosio Grillo Portuondo. Universidad de Ciencias Médicas de Santiago de Cuba.

Especialista de Primer Grado en Medicina Familiar y Primer Grado en Gerontología y Geriatría. Profesor Instructor

Julio Antonio Esquivel Tamayo, Policlínico Manuel Fajardo Rivero. Universidad de Ciencias Médicas de Las Tunas.

Residente de Tercer Año en Medicina General Integral. Diplomado en Medicina Natural Tradicional y Apiterapia. Profesor Instructor. Doctorando en Ciencias Médicas.

References

1. Fruehwirt W, Dorffner G, Roberts S, Gerstgrasser M, Grossegger D, Schmidt R, et al. Associations of event-related brain potentials and Alzheimer’s disease severity: a longitudinal study. Prog Neuropsychopharmacol Biol Psychiatry. 2019;92:31-8. DOI: https://doi.org/10.1016/j.pnpbp.2018.12.013

2. Jadhav C, Kamble P, Mundewadi S, Jaiswal N, Mali S, Ranga S, et al. Clinical applications of EEG as an excellent tool for event related potentials in psychiatric and neurotic disorders. Int J Physiol Pathophysiol Pharmacol. 2022 [acceso 20/10/2024];14(2):73-83. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35619664/

3. Olichney J, Xia J, Church KJ, Moebius HJ. Predictive power of cognitive biomarkers in neurodegenerative disease drug development: utility of the P300 event-related potential. Neural Plast. 2022;2022:2104880. DOI: https://doi.org/10.1155/2022/2104880

4. Gu L, Zhang Z. Exploring potential electrophysiological biomarkers in mild cognitive impairment: a systematic review and meta-analysis of event related potential studies. J Alzheimers Dis. 2017 [acceso 20/10/2024];58(4):1283-92. Disponible en: https://www.j-alz.com/content/exploring-potential-electrophysiological-biomarkers-mild-cognitive-impairment-systematic

5. Tarawneh HY, Mulders WHAM, Sohrabi HR, Martins RN, Jayakody DMP. investigating auditory electrophysiological measures of participants with mild cognitive impairment and alzheimer's disease: a systematic review and meta analysis of event-related potential studies. J Alzheimers Dis. 2021;84(1):419-48. DOI: https://doi.org/10.3233/JAD-210556

6. Montoya-Pedrón A, Ocaña-Montoya CM, Bolaño-Díaz GA. Potencial relacionado con eventos cognitivos P300 en el diagnóstico y clasificación del trastorno neurocognitivo debido a enfermedad de Alzheimer posible. Rev Neurol. 2020;71(1):11-8. DOI: https://doi.org/10.33588/rn.7101.2019341

7. Livingston G, Huntley J, Y Liu K, Costafreda S, Selbaek G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404:572-628. DOI: https://doi.org/10.1016/S0140-6736(24)01296-0

8. Esquivel JA, Montoya A. Factores de riesgo y biomarcadores de la enfermedad de Alzheimer. Rev Cub Med Milit. 2023 [acceso 20/10/2024];53(1). Disponible en: https://revmedmilitar.sld.cu/index.php/mil/article/view/16519

9. Folstein MF, Folstein SE, MCHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of the patients for the clinician. J Psychiatr Res. 1975;12(3):189-98. DOI: https://doi.org/10.1016/0022-3956(75)90026-6

10. American Psychiatric Association. DSM-5. Manual diagnóstico y estadístico de los trastornos mentales. Buenos Aires: Editorial Médica Panamericana; 2016.

11. Gogisetti Y, Pathania M, Mittal S, Yadav P, Kharibam P, Kant R. Assessment of cognition in hypertensives and normotensives: a comparative P300 study. Cureus. 2022;14(8):e28397. DOI: https://doi.org/10.7759/cureus.28397

12. Krivonogova OV, Krivonogova EV, Poskotinova LV. A study of cognitive functions in elderly men from the Arctic region of the Russian Federation with arterial hypertension using the auditory event-related potentials P300. Ekol Chelov. 2024;31(2):162-71. DOI: https://doi.org/10.17816/humeco633767

13. Anandhalakshmi S, Rajkumar R, Arulmurugan K, Kumar J, Thirunavukarasu M. Study of neurocognitive function in type 2 diabetes mellitus patients using P300 event-related potential. Annals Neurosc. 2020;27(3-4):98-103. DOI: https://doi.org/10.1177/0972753120966824

14. Van der Westhuizen N, Biagio-de Jager L, Rheeder P. P300 event-related potentials in normal-hearing adults with type 2 diabetes mellitus. Am J Audiol. 2020;29:120-8. DOI: https://doi.org/10.1044/2019_AJA-19-00095

15. Braverman ER, Chen TJ, Chen AL, Kerner MM, Tung H, Waite RL, et al. Preliminary investigation of plasma levels of sex hormones and human growth factor(s), and P300 latency as correlates to cognitive decline as a function of gender. BMC Res Notes. 2009;2:126. DOI: https://doi.org/10.1186/1756-0500-2-126

16. Rocca W, Grossardt B, Shuster L. Oophorectomy, estrogen, and dementia: A 2014 update. Mol Cell Endocrinol. 2014;389(1-2):7-12. DOI: https://doi.org/10.1016/j.mce.2014.01.020

17. Hedges D, Janis R, Mickelson S, Keith C, Bennett D, Brown BL. P300 amplitude in Alzheimer's disease: a meta-analysis and meta-regression. Clin EEG Neurosci. 2016;47(1):48-55. DOI: https://doi.org/10.1177/1550059414550567

18. Begum T, Reza F, Ahmed I, Abdullah JM. Influence of education level on design-induced N170 and P300 components of event related potentials in the human brain. J Integr Neurosci. 2014;13(1):71-88. DOI: https://doi.org/10.1142/S0219635214500058

Published

2025-06-05

How to Cite

1.
Montoya Pedrón A, Moreno Soto MF, Esquivel Tamayo JA, Pérez Palma HV, Ocaña Montoya CM. Effect of Alzheimer’s disease risk factors on P300 evoked potential. Rev Cubana Inv Bioméd [Internet]. 2025 Jun. 5 [cited 2025 Jul. 30];44. Available from: https://revibiomedica.sld.cu/index.php/ibi/article/view/3552

Issue

Section

ARTÍCULOS ORIGINALES